Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00967655
Title Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Loma Linda Oncology Medical Group, Incorporated
Indications

rectum adenocarcinoma

Therapies

Capecitabine + Panitumumab

Irinotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.